Enex announced June 9 it will acquire 34,270 shares, or a 6.67% stake, in Dermatobio through a third-party allotment rights offering.
The acquisition is valued at 2.00003 billion won (approximately $1.32 million), equivalent to 4.87% of the company's equity capital.
The company said the investment was aimed at "building a shareholding position and generating business synergies."
This content was produced with the assistance of AI translation services.
Tim Cook publicly introduces same-sex partner 'Mike' at Apple farewell event
Aug. 25, 2026
Female YouTuber with 440K subscribers groped, kissed by mob in Tanzania: 'Never travel Africa alone as a woman'
Aug. 31, 2026
Amway Korea launches gut health line backed by 110,000-person Korean microbiome study
Sept. 1, 2026
Aman to open first Korea property in Seoul's Cheongdam-dong
Sept. 2, 2026
Actor Choi Hyun-wook goes live visibly drunk in morning broadcast, alarming fans
Aug. 30, 2026
